Grove Group

Grove Group

Share

Since 1996 Grove Group provides market entry solutions to the CEE countries. We improve patient access to innovative medications in the region by enabling

Aurobindo Pharma to acquire Apotex’ businesses in Poland, Czech Republic, the Netherlands, Spain and Belgium 20/07/2018

Aurobindo Pharma to acquire Apotex’ businesses in Poland, Czech Republic, the Netherlands, Spain and Belgium

http://groveonline.com/aurobindo-pharma-acquire-apotex-businesses-poland-czech-republic-netherlands-spain-belgium/

Aurobindo Pharma announced that its wholly owned step-down subsidiary, Agile Pharma B. V. (Netherlands) has entered into an agreement on 13 July 2018 to acquire commercial operations and certain supporting infrastructure in five European countries viz. the Netherlands, Belgium, Spain, Poland and Czech Republic from Apotex International Inc. a Canadian pharmaceutical company engaged in the manufacture and marketing of pharmaceutical products.


Aurobindo Pharma to acquire Apotex’ businesses in Poland, Czech Republic, the Netherlands, Spain and Belgium

Slovenia and Romania are the Fastest Growing Markets in Europe 12/07/2018

Slovenia and Romania are the Fastest Growing Markets in Europe
http://groveonline.com/slovenia-romania-fastest-growing-markets-europe/
Whilst the latest European Commission 2018 economic growth forecast for the EU stands at 2.3%, a large group of Eastern European countries clearly outpaces its European peers. Slovenia, Romania and Bulgaria lead the pack as shown on the chart below.


Slovenia and Romania are the Fastest Growing Markets in Europe Whilst the latest European Commission 2018 economic growth forecast for the EU stands at 2.3%, a large group of Eastern European countries clearly outpaces its European peers. Slovenia, Romania and Bulgaria lead the pack as shown on the chart below.

Bulgaria’s Sopharma Trading to grow operations in Serbia 04/07/2018

Bulgaria’s Sopharma Trading to grow operations in Serbia
http://groveonline.com/bulgarias-sopharma-trading-grow-operations-serbia/
SOFIA (Bulgaria), June 22 (SeeNews) - Bulgarian drug distributor and retailer Sopharma Trading [BUL:SO5] plans to expand its operations on the Serbian market and to become a strategic investor in Southeast Europe (SEE), it said.


Bulgaria’s Sopharma Trading to grow operations in Serbia SOFIA (Bulgaria), June 22 (SeeNews) - Bulgarian drug distributor and retailer Sopharma Trading [BUL:SO5] plans to expand its operations on the Serbian market and to become a strategic investor in Southeast Europe (SEE), it said.

Sun Pharma enters Azerbaijani market 26/06/2018

Sun Pharma enters Azerbaijani market
http://groveonline.com/sun-pharma-enters-azerbaijani-market/
Azerbaijan’s Sumgait city has hosted the groundbreaking ceremony of the first plant for the production of solid drugs.
The ceremony was attended by Azerbaijan’s Economy Minister Shahin Mustafayev.


Sun Pharma enters Azerbaijani market During the event, it was noted that products of the plant, which is being built by India’s Sun Pharmaceutical Industries Ltd. (Sun Pharma), will meet the European GMP (Good Manufacturing Practice) standards.

19/06/2018

Poland might not be the first place you associate with biotech, but the country is becoming an emerging hotspot for pharmaceutical companies and biotech startups
http://groveonline.com/poland-place-associate-biotech-country-emerging-hotspot-pharmaceutical-companies-biotech-startups/
Although Poland has a very strong scientific base in life sciences and medicine, it has not developed a vibrant biotech or medtech sectors. Until recently, no truly innovative products from Poland have been introduced to the global market.


Czech Republic mulls new reimbursement rules for medical devices 29/05/2018

Czech Republic mulls new reimbursement rules for medical devices
http://groveonline.com/czech-republic-mulls-reimbursement-rules-medical-devices/
The Czech Health Ministry prepared draft amendments to the Public Health Insurance Act, which will introduce new reimbursement rules for medical devices, the Ministry said.


Czech Republic mulls new reimbursement rules for medical devices The Czech Health Ministry prepared draft amendments to the Public Health Insurance Act, which will introduce new reimbursement rules for medical devices, the Ministry said.

Lithuania – Update on ‘Sunset Clause’ Requirements for Medicinal Products 10/05/2018

Lithuania – Update on ‘Sunset Clause’ Requirements for Medicinal Products
http://groveonline.com/lithuania-update-sunset-clause-requirements-medicinal-products/
The State Medicines Control Agency on the ground of market monitoring data has compiled the list of medicinal products authorized in the Republic of Lithuania which more than for three years had not been supplied to the Lithuanian market.


Lithuania – Update on ‘Sunset Clause’ Requirements for Medicinal Products The State Medicines Control Agency on the ground of market monitoring data has compiled the list of medicinal products authorized in the Republic of Lithuania which more than for three years had not been supplied to the Lithuanian market.

New payment requirements of a Bulgarian Drug Agency 08/05/2018

New payment requirements of a Bulgarian Drug Agency
http://groveonline.com/payment-requirements-bulgarian-drug-agency/
In February 2018, the Bulgarian Drug Agency (BDA) announced new requirements for fee payments which are important for all applicants, marketing authorisation holders and their representatives.


New payment requirements of a Bulgarian Drug Agency In February 2018, the Bulgarian Drug Agency (BDA) announced new requirements for fee payments which are important for all applicants, marketing authorisation holders and their representatives.

Kazakh domestic pharmaceutical production up 79.8 percent in 2017 27/04/2018

Kazakh domestic pharmaceutical production up 79.8 percent in 2017
http://groveonline.com/kazakh-domestic-pharmaceutical-production-79-8-percent-2017/
ASTANA – The Kazakh pharmaceutical industry increased production of the country’s most popular medications by 73.1 percent with production increasing 79.8 percent over 2016.

Kazakh domestic pharmaceutical production up 79.8 percent in 2017
http://groveonline.com/kazakh-domestic-pharmaceutical-production-79-8-percent-2017/
ASTANA – The Kazakh pharmaceutical industry increased production of the country’s most popular medications by 73.1 percent with production increasing 79.8 percent over 2016.


Kazakh domestic pharmaceutical production up 79.8 percent in 2017 ASTANA – The Kazakh pharmaceutical industry increased production of the country’s most popular medications by 73.1 percent with production increasing 79.8 percent over 2016. Prices for pharmaceutical products in Kazakhstan have also increased 6.6 percent over the last 12 months.

Romania on the last place in EU for medical drugs consumption 19/04/2018

Romania on the last place in EU for medical drugs consumption
http://groveonline.com/romania-place-eu-medical-drugs-consumption/
Romania is at the bottom of a European ranking regarding the consumption of medical drugs per capita, but not because they are healthier, but due to the precarious access to therapeutic solutions, according to the Trade Union of Industrial Medical Drugs Producers in Romania (PRIMER).


Romania on the last place in EU for medical drugs consumption Romania is at the bottom of a European ranking regarding the consumption of medical drugs per capita, but not because they are healthier, but due to the precarious access to therapeutic solutions, according to the Trade Union of Industrial Medical Drugs Producers in Romania (PRIMER).

Want your school to be the top-listed School/college in Chichester?

Click here to claim your Sponsored Listing.

Location

Address

Cawley Place, 15 Cawley Road, Chichester, West Sussex 1UZ
Chichester
PO19